Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis,
peripheral and/or axial spondyloarthritis, Crohn's disease, and ulcerative colitis, are …

Biological agents have in the last two decades become very important therapeutic agents,
particularly for the treatment of various autoimmune disorders. The most widely used …

Introduction Hepatotoxicity induced by immunotherapeutics is an appearing cause for
immune-mediated drug-induced liver injury. Such immuno-toxic mechanisms are difficult to …

Abstract The world's 1.4 million lakes (≥ 10 ha) provide many ecosystem services that are
essential for human well‐being; however, only if their health status is good. Here, we …

ABSTRACT Introduction Drug induced Liver-Injury (DILI) is a leading cause of drug attrition
and complex in vitro models (CIVMs), including three dimensional (3D) spheroids, 3D bio …

Hepatitis B virus (HBV) reactivation is a clinically significant challenge in disease
management. This review explores the immunological mechanisms underlying HBV …

Immunological checkpoint inhibitors (ICIs) have revolutionized therapy of many different
malignanices. Concomitant immune-mediated adverse effects are common and can affect …

In this issue of Medical Clinics of North America, guest editors Drs. Anand V. Kulkarni and K.
Rajender Reddy bring their considerable expertise to the topic of Hepatology: An Update …

Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury
Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury Ann …